Daniel Cantillon, MD, said the first leadless, dual-chamber pacing system performed very well in the Aveir dual-chamber i2i trial. #HRS #HRS23

Early success of dual-chamber leadless pacemaker suggests big changes could be on the horizon

Daniel Cantillon, MD, explained why the positive performance of Abbott's Aveir dual-chamber leadless pacemaker could lead to considerable improvements in patient care. 

A figure from the HRS remote monitoring consensus document on staffing challenges with remote monitoring.

Electrophysiology experts issue recommendations for remote monitoring of CIEDs

The Heart Rhythm Society released a new expert consensus statement on the management of remote device clinics for implantable EP devices.

The EBR Systems WiSE leadless cardiac resynchronization therapy (CRT) system. #HRS23

A leadless pacemaker the size of a grain of rice delivers cardiac resynchronization therapy

Results from a pivotal clinical trial presented as a late-breaker at Heart Rhythm 2023 indicate that a new leadless pacemaker technology can deliver cardiac resynchronization therapy in patients who were not able to be treated with conventional CRT and epicardial leads.

Left bundle branch pacing emerges as an alternative to biventricular pacing in two late-breaking trials

The use of left bundle branch area pacing (LBBAP) is growing in electrophysiology implanted devices. Two late-breaking studies at Heart Rhythm 2023 highlight the success of LBBAP as an alternative to the standard of care using biventricular pacing.

Thumbnail

‘Promising’ results as first patients undergo PCI with next-generation pVAD device

The new product from California-based Supira Medical was designed to limit hemolysis and other complications among patients undergoing high-risk PCI or in cardiogenic shock

Thumbnail

Marijuana use linked to much higher risk of peripheral artery disease

New research presented at SCAI Scientific Sessions 2023 suggests that marijuana users should understand the early warning signs of PAD, including feelings of pain and coldness in the leg. 

Abbott TriClip device for TEER

EuroPCR 2023: Late-breaking research examines the latest in TEER, TAVR and PCI outcomes

Catch up on key late-breaking research from Abbott, Edwards Lifesciences and Philips presented at the four-day meeting in Paris. 

Thumbnail

Links to all the late-breaking trials for Heart Rhythm 2023

Heart Rhythm 2023, the society's 44th annual meeting, is scheduled for May 19-21. 

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.